Home › Companies › AGILON HEALTH INC. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and AGILON HEALTH INC.’s Form 8-K, filed May 30, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 28, 2025: 4 items on AGILON HEALTH INC.’s Form 8-K, filed May 30, 2025: 2 elected · 2 approved.
Notable dissent: 1 director (14.7% against); 1 say-on-pay vote (77.4% support).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore AGILON HEALTH INC. in the interactive database Compare manager voting policies
These tallies are AGILON HEALTH INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 30, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Silvana Battaglia | 367,732,187 | 2,575,657 | 73,996 | -- | 19,577,901 | 99.3% | Elected | — |
| Elect Director: Sharad Mansukani, M.D. | 316,017,915 | 54,325,054 | 38,871 | -- | 19,577,901 | 85% | Elected | — |
| 2. Ratification of Independent Registered Public Accounting Firm | 385,547,549 | 4,346,548 | 65,644 | -- | -- | 99% | Approved | — |
| 3. Non-Binding Vote on Executive Compensation | 286,771,841 | 83,515,983 | 94,016 | -- | 19,577,901 | 77% | Approved | — |
Source: AGILON HEALTH INC., Form 8-K, filed with the SEC on May 30, 2025 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
177 asset managers disclosed a vote on at least one AGILON HEALTH INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
85% Majority: yes · of votes cast
Description as filed by funds: Election of Class I Directors: Sharad Mansukani, M.D.
AGILON HEALTH INC.’s own tally for this item (“Elect Director: Sharad Mansukani, M.D.”): 316,017,915 for, 54,325,054 against, per its Form 8-K filed May 30, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal No. 1 - Election of Directors The following two individuals were elected to the Company's Board of Directors to serve as Class I directors until the Company's 2028 annual meeting of stockholders and until their successors have been duly elected and qualified.”
Support: 85% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 53 asset managers below reported 172,455,298 for, 22,625,125 against, 31,549 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 65,184,327 | 0 | 0 | 0 | For |
| Vanguard | 35,662,457 | 62,800 | 0 | 0 | For |
| Fidelity | 27,540,308 | 219,883 | 0 | 0 | For |
| Morgan Stanley | 20,314,070 | 0 | 0 | 0 | For |
| BlackRock | 0 | 11,091,520 | 0 | 0 | Against |
| Brighthouse | 7,214,827 | 113,767 | 0 | 0 | For |
| NEW ECONOMY FUND | 5,866,895 | 0 | 0 | 0 | For |
| TIAA | 0 | 5,791,820 | 0 | 0 | Against |
| Charles Schwab | 4,929,028 | 0 | 0 | 0 | For |
| Equitable | 3,177,976 | 818,886 | 0 | 0 | Mixed |
| Hartford | 800,962 | 0 | 0 | 0 | For |
| Invesco | 0 | 715,488 | 0 | 0 | Against |
| Exchange Place Advisors Trust | 0 | 672,080 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 0 | 518,720 | 0 | 0 | Against |
| Global X | 0 | 409,144 | 0 | 0 | Against |
| Goldman Sachs | 0 | 399,439 | 0 | 0 | Against |
| JPMorgan | 395,946 | 0 | 0 | 0 | For |
| State Street | 381,535 | 1,048 | 0 | 0 | For |
| Lincoln Financial | 285,005 | 16,528 | 0 | 0 | Mixed |
| DWS | 0 | 245,556 | 0 | 0 | Against |
| TIFF INVESTMENT PROGRAM | 0 | 228,279 | 0 | 0 | Against |
| NORTHERN LIGHTS FUND TRUST III | 184,911 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 169,668 | 0 | 0 | Against |
| Northern Trust | 0 | 157,172 | 0 | 0 | Against |
| American Century | 0 | 144,998 | 0 | 0 | Against |
Showing the 25 largest of 53 asset managers. All 53 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
Description as filed by funds: Election of Class I Directors: Silvana Battaglia
AGILON HEALTH INC.’s own tally for this item (“Elect Director: Silvana Battaglia”): 367,732,187 for, 2,575,657 against, per its Form 8-K filed May 30, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal No. 1 - Election of Directors The following two individuals were elected to the Company's Board of Directors to serve as Class I directors until the Company's 2028 annual meeting of stockholders and until their successors have been duly elected and qualified.”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 47 asset managers below reported 180,788,900 for, 303,747 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 65,184,327 | 0 | 0 | 0 | For |
| Vanguard | 29,718,275 | 0 | 0 | 0 | For |
| Fidelity | 26,889,225 | 0 | 0 | 0 | For |
| Morgan Stanley | 20,314,070 | 0 | 0 | 0 | For |
| BlackRock | 11,091,520 | 0 | 0 | 0 | For |
| Brighthouse | 6,476,545 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 5,866,895 | 0 | 0 | 0 | For |
| TIAA | 5,791,820 | 0 | 0 | 0 | For |
| Equitable | 3,996,862 | 0 | 0 | 0 | For |
| Invesco | 715,488 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 672,080 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 518,720 | 0 | 0 | 0 | For |
| Goldman Sachs | 399,439 | 0 | 0 | 0 | For |
| JPMorgan | 395,946 | 0 | 0 | 0 | For |
| State Street | 382,583 | 0 | 0 | 0 | For |
| Lincoln Financial | 285,005 | 16,528 | 0 | 0 | Mixed |
| DWS | 245,556 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 228,279 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST III | 0 | 184,911 | 0 | 0 | Against |
| AIG/SunAmerica | 169,668 | 0 | 0 | 0 | For |
| Northern Trust | 157,172 | 0 | 0 | 0 | For |
| American Century | 144,998 | 0 | 0 | 0 | For |
| T. Rowe Price | 137,910 | 0 | 0 | 0 | For |
| Voya | 133,598 | 0 | 0 | 0 | For |
| John Hancock | 111,897 | 0 | 0 | 0 | For |
Showing the 25 largest of 47 asset managers. All 47 are in the interactive database (link above).
Combines 8 wordings of this item as funds reported it.
77% Approved · of votes cast
Prior year: 82.8% for (May 29, 2024 meeting) ▼ 5.4 pts
Description as filed by funds: To approve, by advisory vote, the compensation paid to the Company's named executive officers.
AGILON HEALTH INC.’s own tally for this item (“3. Non-Binding Vote on Executive Compensation”): 286,771,841 for, 83,515,983 against — passed, per its Form 8-K filed May 30, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal No. 3 - Non-Binding Vote on Executive Compensation The stockholders approved, on an advisory, non-binding basis, the compensation paid to the Company's named executive officers.”
Support: 77% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 0 | 65,184,327 | 0 | 0 | Against |
| Vanguard | 35,725,257 | 0 | 0 | 0 | For |
| Fidelity | 27,760,191 | 0 | 0 | 0 | For |
| Morgan Stanley | 20,314,070 | 0 | 0 | 0 | For |
| BlackRock | 11,091,520 | 0 | 0 | 0 | For |
| Brighthouse | 7,328,594 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 0 | 5,866,895 | 0 | 0 | Against |
| TIAA | 5,791,820 | 0 | 0 | 0 | For |
| Charles Schwab | 4,929,028 | 0 | 0 | 0 | For |
| Equitable | 3,996,862 | 0 | 0 | 0 | For |
| Hartford | 800,962 | 0 | 0 | 0 | For |
| Invesco | 0 | 715,488 | 0 | 0 | Against |
| Exchange Place Advisors Trust | 9,549 | 662,531 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 518,720 | 0 | 0 | 0 | For |
| Global X | 0 | 409,144 | 0 | 0 | Against |
| Goldman Sachs | 399,439 | 0 | 0 | 0 | For |
| JPMorgan | 395,946 | 0 | 0 | 0 | For |
| State Street | 382,583 | 0 | 0 | 0 | For |
| Lincoln Financial | 285,005 | 16,528 | 0 | 0 | Mixed |
| DWS | 245,556 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 0 | 228,279 | 0 | 0 | Against |
| NORTHERN LIGHTS FUND TRUST III | 0 | 184,911 | 0 | 0 | Against |
| AIG/SunAmerica | 169,668 | 0 | 0 | 0 | For |
| Northern Trust | 157,172 | 0 | 0 | 0 | For |
| American Century | 0 | 144,998 | 0 | 0 | Against |
Fund voting reports, all 54 managers: 121,653,549 for, 73,537,394 against, 31,549 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Clayton, Dubilier & Rice, LLC | 100,000,000 | 0 | 0 | 0 | For |
| Capital Group | 52 | 75,334,408 | 0 | 0 | Against |
| Morgan Stanley | 47,647,780 | 0 | 0 | 0 | For |
| Fidelity | 20,580,324 | 0 | 0 | 0 | For |
| Wellington | 13,509,685 | 0 | 0 | 0 | For |
| BlackRock | 10,442,103 | 2,942 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 6,987,748 | 0 | 0 | 0 | For |
| Rock Springs Capital Management LP | 6,950,000 | 0 | 0 | 0 | For |
| State Street | 6,300,378 | 0 | 0 | 0 | For |
| Rubicon Founders LLC | 0 | 0 | 6,292,396 | 0 | Abstain |
| Nuveen | 5,829,174 | 0 | 0 | 0 | For |
| Charles Schwab | 4,929,040 | 0 | 0 | 0 | For |
| Northern Trust | 2,430,775 | 0 | 0 | 0 | For |
| Amundi | 0 | 1,484,709 | 0 | 0 | Against |
| MELLON INVESTMENTS Corp | 976,727 | 0 | 0 | 0 | For |
| JPMorgan | 949,930 | 0 | 0 | 0 | For |
| Invesco | 0 | 900,733 | 0 | 0 | Against |
| Vanguard | 885,754 | 0 | 0 | 0 | For |
| DE Shaw | 846,689 | 0 | 0 | 0 | For |
| ALGERT GLOBAL LLC | 0 | 798,011 | 0 | 0 | Against |
| T. Rowe Price | 596,000 | 0 | 0 | 0 | For |
| Citadel | 531,950 | 0 | 0 | 0 | For |
| KENNEDY CAPITAL MANAGEMENT LLC | 443,629 | 0 | 0 | 0 | For |
| UBS | 438,932 | 0 | 0 | 0 | For |
| AllianceBernstein | 436,463 | 0 | 0 | 0 | For |
Institutional-manager reports, all 141 managers: 234,283,087 for, 80,493,851 against, 6,292,396 abstained. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99% Approved · of votes cast
Prior year: 99.7% for (May 29, 2024 meeting) ▼ 0.8 pts
Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2025.
AGILON HEALTH INC.’s own tally for this item (“2. Ratification of Independent Registered Public Accounting Firm”): 385,547,549 for, 4,346,548 against — passed, per its Form 8-K filed May 30, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal No. 2 - Ratification of Independent Registered Public Accounting Firm The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 54 asset managers below reported 195,190,943 for, 31,549 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 65,184,327 | 0 | 0 | 0 | For |
| Vanguard | 35,725,257 | 0 | 0 | 0 | For |
| Fidelity | 27,760,191 | 0 | 0 | 0 | For |
| Morgan Stanley | 20,314,070 | 0 | 0 | 0 | For |
| BlackRock | 11,091,520 | 0 | 0 | 0 | For |
| Brighthouse | 7,328,594 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 5,866,895 | 0 | 0 | 0 | For |
| TIAA | 5,791,820 | 0 | 0 | 0 | For |
| Charles Schwab | 4,929,028 | 0 | 0 | 0 | For |
| Equitable | 3,996,862 | 0 | 0 | 0 | For |
| Hartford | 800,962 | 0 | 0 | 0 | For |
| Invesco | 715,488 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 672,080 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 518,720 | 0 | 0 | 0 | For |
| Global X | 409,144 | 0 | 0 | 0 | For |
| Goldman Sachs | 399,439 | 0 | 0 | 0 | For |
| JPMorgan | 395,946 | 0 | 0 | 0 | For |
| State Street | 382,583 | 0 | 0 | 0 | For |
| Lincoln Financial | 301,533 | 0 | 0 | 0 | For |
| DWS | 245,556 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 228,279 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST III | 184,911 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 169,668 | 0 | 0 | 0 | For |
| Northern Trust | 157,172 | 0 | 0 | 0 | For |
| American Century | 144,998 | 0 | 0 | 0 | For |
Showing the 25 largest of 54 asset managers. All 54 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 413,023,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Capital Group | 15.78% |
| 2 | Vanguard | 8.65% |
| 3 | Fidelity | 6.72% |
| 4 | Morgan Stanley | 4.92% |
| 5 | BlackRock | 2.69% |
| 6 | Brighthouse | 1.77% |
| 7 | NEW ECONOMY FUND | 1.42% |
| 8 | TIAA | 1.40% |
| 9 | Charles Schwab | 1.19% |
| 10 | Equitable | 0.97% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Clayton, Dubilier & Rice, LLC | 24.21% |
| 2 | Capital Group | 18.24% |
| 3 | Morgan Stanley | 11.54% |
| 4 | Fidelity | 4.98% |
| 5 | Wellington | 3.27% |
| 6 | BlackRock | 2.53% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 1.69% |
| 8 | Rock Springs Capital Management LP | 1.68% |
| 9 | State Street | 1.53% |
| 10 | Rubicon Founders LLC | 1.52% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Morgan Stanley | 52,033,701 | 12.60% | Form 13F, quarter ended March 31, 2025 |
| North Peak Capital Management, LLC | 39,411,957 | 9.54% | Schedule 13G, filed November 13, 2025 |
| Vanguard Group | 30,285,760 | 7.33% | Form 13F, quarter ended March 31, 2025 |
| BlackRock | 24,736,658 | 5.99% | Form 13F, quarter ended March 31, 2025 |
| FMR (Fidelity) | 19,097,967 | 4.62% | Form 13F, quarter ended March 31, 2025 |
| Wellington Management | 14,986,897 | 3.63% | Form 13F, quarter ended March 31, 2025 |
| Capital World Investors | 10,852,943 | 2.63% | Schedule 13G, filed September 5, 2025 |
| Capital International Investors | 9,892,742 | 2.40% | Schedule 13G, filed August 13, 2025 |
| Citadel Advisors | 8,388,108 | 2.03% | Form 13F, quarter ended March 31, 2025 |
| State Street | 7,401,608 | 1.79% | Form 13F, quarter ended March 31, 2025 |
Percentages above are of 413,023,000 shares outstanding, as reported by AGILON HEALTH INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At AGILON HEALTH INC.'s shareholder meeting held May 28, 2025, in the 2024-2025 proxy season, 177 asset managers reported votes on at least one of its 4 ballot items in their SEC Form N-PX filings, covering 908 separate fund positions. On the most widely held item on that ballot — To approve, by advisory vote, the compensation paid to the Company's named executive officers. — AGILON HEALTH INC.'s filing reports the proposal as approved, with 77% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: AGILON HEALTH INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 30, 2025.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from AGILON HEALTH INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
AGILON HEALTH INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “AGILON HEALTH (AGL) 2025 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/agilon-health-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.